301902
Adverse Childhood Experiences and the Risk of Chronic Disease and Disability — Results from Ten U.S. States and the District of Columbia, 2010
Methods: Ten states and the District of Columbia included an optional ACEs module in the 2010 Behavioral Risk Factor Surveillance Survey, a national cross-sectional, random-digit-dial telephone survey of adults. Respondents were asked about nine ACEs including physical, sexual, and emotional abuse and household member mental illness, alcoholism, drug abuse, imprisonment, divorce, and intimate partner violence. An ACE score was calculated for each subject by summing the number of ACE items endorsed. After controlling for sociodemographic variables, weighted adjusted odds ratios were calculated for self-reported health conditions given exposure to 0, 1-3, 4-6, or 7-9 ACEs.
Results: Compared to those who reported no ACE exposure, the adjusted odds of reporting myocardial infarction; asthma; fair/poor health; frequent mental distress; and disability were higher for those reporting 1-3, 4-6, and 7-9 ACEs. The odds of reporting coronary heart disease and stroke were higher for those who reported 4-6 and 7-9 ACEs; and the odds of diabetes was higher for those reporting 1-3 and 4-6 ACEs.
Conclusion: These findings underscore the importance of child maltreatment prevention as a means to mitigate adult morbidity and mortality.
Learning Areas:
Chronic disease management and preventionLearning Objectives:
Demonstrate that violence in childhood contributes to the leading causes of death and disability in adults and describe possible pathways for how this occurs
Keyword(s): Child Abuse, Chronic Disease Prevention
Qualified on the content I am responsible for because: I am a physician who has a master's in maternal and child health and has devoted most of my research career to violence against women and children. I am an epidemiologist for the CDC Violence Against Children and Youth Team within the Division of Violence Prevention.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.